Neuros adds Scott Drees to board of directors
This article was originally published in Clinica
Scott Drees has joined the board of directors of neurostimulation firm Neuros Medical, as an independent member. Mr Drees brings extensive experience in neurostimulation to Neuros – he has previously held senior-level executive positions at Johnson & Johnson, Boston Scientific, St Jude Medical and Advanced Neuromodulation Systems. Cleveland, Ohio-based Neuros is currently developing Nerve Block, a stimulation device that is designed to eliminate chronic pain, specifically residual limb pain.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals